Author:
Brousseau Margaret E.,Schaefer Ernst J.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference45 articles.
1. American Heart Association: 2001 Heart and Stroke Statistical update. Dallas, TX: American Heart Association; 2001.
2. LaRosa JC, He J, Vupputuri S: Effect of statins on risk of coronary heart disease: a meta-analysis of randomized controlled trials. JAMA 1999, 282:2340–2346.
3. Genest JJ Jr, McNamara JR, Ordovas JM, et al.: Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein(a) abnormalities in men with premature coronary heart disease. J Am Coll Cardiol 1992, 19:792–802.
4. van Heek M, France CF, Compton DS, et al.: In vivo mechanism-based discovery of a potent cholesterol absorption inhibitor (SCH58235) through the identification of active metabolites of SCH48461. J Pharmacol Exp Ther 1997, 283:157–163.
5. Rosenblum SB, Huynh T, Alonso A, et al.: Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption. J Med Chem 1998, 41:973–980.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献